David Bode
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Integrated left ventricular multi-omics landscape of human cardiometabolic HFpEF.
Journal: Cardiovascular research
Published: March 05, 2026
Cardiac oxygen consumption in atrial fibrillation: A heart out of breath.
Journal: American heart journal
Published: April 11, 2025
Systems Biology Approach Uncovers Candidates for Liver-Heart Interorgan Crosstalk in HFpEF.
Journal: Circulation research
Published: August 29, 2024
Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications.
Journal: Nature reviews. Cardiology
Published: April 22, 2024
Impairment of the adrenergic reserve associated with exercise intolerance in a murine model of heart failure with preserved ejection fraction.
Journal: Acta physiologica (Oxford, England)
Published: August 03, 2023
Cardiac metabolism in HFpEF: from fuel to signalling.
Journal: Cardiovascular research
Published: July 25, 2022
Up next: The dawn of systems biology in HFpEF research.
Journal: Journal of molecular and cellular cardiology
Published: April 09, 2022
Canagliflozin and myocardial oxidative stress: SGLT1 inhibition takes centre stage.
Journal: European heart journal
Published: August 09, 2021
Implications of SGLT Inhibition on Redox Signalling in Atrial Fibrillation.
Journal: International journal of molecular sciences
Published: April 26, 2021
Oxidative Stress and Inflammatory Modulation of Ca2+ Handling in Metabolic HFpEF-Related Left Atrial Cardiomyopathy.
Journal: Antioxidants (Basel, Switzerland)
Published: August 20, 2020
Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF.
Journal: Cardiovascular diabetology
Published: August 04, 2020
Last Updated: 09/26/2026